| Sarah Proulx, AUD | |
|
160 West St, Building 1, Suite B, Cromwell, CT 06416-2441 | |
| (860) 632-5003 | |
| (860) 632-5532 |
| Full Name | Sarah Proulx |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 14 Years |
| Location | 160 West St, Cromwell, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083925929 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 000491 (Connecticut) | Secondary |
| 237600000X | Audiologist-hearing Aid Fitter | 000491 (Connecticut) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Center For Better Hearing, Llc | 0941472237 | 2 |
News Archive
NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services today reported its results for the first quarter of 2014.
HIV/AIDS patients need their doctors to pay more attention to their other health conditions that can be exacerbated by HIV or its treatments, especially now that people are living longer with HIV. That is according to a international study of 2,000 patients that two Chicago-area health providers were instrumental in carrying out.
Inter Press Service profiles a program launched by the Drugs for Neglected Diseases Initiative (DNDi) to develop antiretroviral drugs (ARVs) specifically designed for children living with HIV/AIDS.
An advisory panel for the Food and Drug Administration (FDA) in the U.S. has recommended that the drug-coated stents used in patients with cardiovascular disease should carry a warning.
› Verified 5 days ago
| Provider Name | Center For Better Hearing, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1861604506 PECOS PAC ID: 0941472237 Enrollment ID: O20111010000548 |
News Archive
NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services today reported its results for the first quarter of 2014.
HIV/AIDS patients need their doctors to pay more attention to their other health conditions that can be exacerbated by HIV or its treatments, especially now that people are living longer with HIV. That is according to a international study of 2,000 patients that two Chicago-area health providers were instrumental in carrying out.
Inter Press Service profiles a program launched by the Drugs for Neglected Diseases Initiative (DNDi) to develop antiretroviral drugs (ARVs) specifically designed for children living with HIV/AIDS.
An advisory panel for the Food and Drug Administration (FDA) in the U.S. has recommended that the drug-coated stents used in patients with cardiovascular disease should carry a warning.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Proulx, AUD 160 West St, Building 1, Suite B, Cromwell, CT 06416-2441 Ph: (860) 632-5003 | Sarah Proulx, AUD 160 West St, Building 1, Suite B, Cromwell, CT 06416-2441 Ph: (860) 632-5003 |
News Archive
NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services today reported its results for the first quarter of 2014.
HIV/AIDS patients need their doctors to pay more attention to their other health conditions that can be exacerbated by HIV or its treatments, especially now that people are living longer with HIV. That is according to a international study of 2,000 patients that two Chicago-area health providers were instrumental in carrying out.
Inter Press Service profiles a program launched by the Drugs for Neglected Diseases Initiative (DNDi) to develop antiretroviral drugs (ARVs) specifically designed for children living with HIV/AIDS.
An advisory panel for the Food and Drug Administration (FDA) in the U.S. has recommended that the drug-coated stents used in patients with cardiovascular disease should carry a warning.
› Verified 5 days ago